NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Deepak Nitrite Faces Challenges in Polycarbonate Resin Market

The Indian polycarbonate (PC) resin demand has been growing at a remarkable 14% Compound Annual Growth Rate (CAGR) during the period of 2020-25. However, a significant portion of this demand is being met through imports, which account for all of the demand in the country. The upcoming 165 tonnes per annum (tmt) PC resin capacity addition by Deepak Nitrite is expected to help reduce the country's reliance on imports.

Despite this positive development, the PC resin industry is facing significant challenges, including overcapacity and poor utilization. In recent times, around 5% of global capacity has been forced to shut down due to these issues. The upcoming fully integrated PC resin capacity addition by Deepak Nitrite, valued at INR85 billion, may have an adverse impact on the company's return ratios. This is particularly concerning since the company's Trinseo plant is based on older technology from Dow and is primarily designed to produce commodity-grade PC.

CompanyGlobal Capacity Shutdown (%)
Deepak Nitrite0%
Industry Average5%

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

As a result of these factors, we have downgraded our recommendation for Deepak Nitrite to 'REDUCE' with a target price of INR1,354. The recent rally in the stock has made the risk-reward profile unfavorable, prompting us to take this stance.

Investor Takeaway

Investors should consider reducing their exposure to Deepak Nitrite due to unfavorable risk-reward post recent rally.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.